Study of Determination and Effect of The Level of Copper, Zinc, Selenium and Body Mass-Index in Hyperlipidemia Patients in Babylon Province


  • Huda Ahmed Duhaib Department of Biochemistry, College of Medicine, University of Babylon, Iraq
  • Mufeed Jalil Ewadh Department of Chemistry and Biochemistry, College of Medicine, Babylon University
  • Tariq Hussein Mgheer Department of Chemistry and Biochemistry, College of Medicine, Babylon University


hyperlipidemia, zinc, copper, selenium, body mass index


Background:  Hyperlipidemia is common in public, the link between trace elements and Hyperlipidemia is not clearly studied. For humans, copper, zinc and selenium are essential trace elements in nutrients and required in very small quantities for various biological functions. During disease, trace elements used for diagnosis, it is essential to distinguish whether the balance is altered in free or bound elements. Objective: For the assessment of copper, zinc, selenium and body mass index level and to examine the correlation between parameters and study the probable relation of them with diagnosis of hyperlipidemia in Babylon province. Materials and Methods:  Cu, Zn and Se were estimated in one  hundred subjects; 50 patients with hyperlipidemia and 50 healthy subjects were participated in this study. Patients and control groups with an age ranged between (19-75) years. The level of Zn and Cu and Se were assessed in serum by Flameless Atomic absorption spectrophotometer method. Results: Serum levels of selenium and zinc displayed a significant decrease, while serum copper significantly elevated (p < 0.001) in hyperlipidemia patients. On the other hand, selenium and zinc correlated significantly with body mass index. Conclusion:  Among hyperlipidemia patients in Babylon province, the variability in some trace elements indicate the significant relationship with hyperlipidemia.  


- Shattat G.F. A review article on hyperlipidemia: types, treatments and new drug targets. Biomedical and Pharmacology Journal. 2015; 7(1): 399-409.

- Naser I H, Abd Alkareem Z, Mosa A U. Hyperlipidemia: pathophysiology, causes, complications, and treatment. A review. kerbala journal of pharmaceutical sciences. 2021;1(19): 1-15.

- Rafieian-Kopaei M, et al. Atherosclerosis: process, indicators, risk factors and new hopes. International journal of preventive medicine. 2014; 5(8): 927.

- Bahmani M, Mirhoseini M, Shirzad H, Sedighi M, Shahinfard N, RafieianKopaei M. A review on promising natural agents effective on hyperlipidemia. Journal of evidence-based complementary & alternative medicine. 2015;2 (3) :228-235.

- Nirosha K, et al. A review on hyperlipidemia. International Journal of Novel Trends in Pharmaceutical Sciences. 2014; 4(5):81-92.

- Takemoto M and J.K. Liao. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arteriosclerosis, thrombosis, and vascular biology. 2001; 21(11):1712-1719.

- Ward N C, Watts G Fand Eckel RH. Statin toxicity: mechanistic insights and clinical implications. Circulation research. 2019; 124(2): 328-350.

- Namama S. Hamad1, Dler. M. Salh1, Avan A. Ahmed2.. Compared levels of specific divalent trace elements in hyperlipidemia and hepatitis sera patients. Advances in Life Science and Technology.2014;17:1-5.

- Hamid A Z A, et al. Effect of statin therapy on serum trace element status in dyslipidemic patients: Results of a placebo-controlled cross-over trail. Clinical Biochemistry. 2011; 13(44): S152.

- Gao Z, Chen Z, Sun A, Deng X. Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices 4. 2019;100025.

- DiNicolantonio J J, Mangan D and O’Keefe J H. Copper deficiency may be a leading cause of ischaemic heart disease. Open heart. 2018; 5(2): e000784.

- Ward N C, Watts G F, Eckel R H. Statin toxicity: mechanistic insights and clinical implications. Circulation research. 2019;124(2), 328-350.

- Caballero B, Trugo L C, Finglas P M. Encyclopedia of food sciences and nutrition. Academic .2003.

- McCullough PA, et al.Treatment of hypertriglyceridemia with fibric acid derivatives: impact on lipid subfractions and translation into a reduction in cardiovascular events. Reviews in cardiovascular medicine. 2011;12(4): 173-185.

- Sturm R. Increases in morbid obesity in the USA: 2000–2005. Public Health. 2007 ; 121 (7), 492–6.

- Baiee H A, Makai M B. Medication adherence in hypertensive diabetic patients. Medical journal of Babylon. 2022; 19(4): 129-139.

- Zujie Gao, Zengsheng Chen, Anqiang Sun. Gender differences in cardiovascular disease. Medicine in Novel Technology and Devices. 2019;4.

- Brown CD, et al. Body mass index and the prevalence of hypertension and dyslipidemia. Obesity research. 2000; 8(9): 605-619.

- Wang M, Hou X, Hu W, Chen L, Chen S. Serum lipid and lipoprotein levels of middle-aged and elderly Chinese men and women in Shandong Province. Lipids Health Dis. 2019;18(1):58-65.

- Al Obeidy B F, Al Zobair A A, Jawher N M T, Zheng F. Relationship between vitamin D3 level and body mass index in postmenopausal breast cancer patients. Medical journal of Babylon. 2022; 19(4): 207-222.

- Arnett DK, Blumenthal RS, Albert MA, Buroker AB, Goldberger ZD, Hahn EJ, et al. ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;140(11):563–595.

- Rayman MP. The importance of selenium to human health. The lancet. 2000; 356(9225): 233-241.

- Ferns G A, Lamb D J and Taylor A. The possible role of copper ions in atherogenesis: the Blue Janus. Atherosclerosis, 1997;133(2): 139-152.

- Channon K M, Qian H and George S E. Nitric oxide synthase in atherosclerosis and vascular injury: insights from experimental gene therapy. Arteriosclerosis, thrombosis, and vascular biology.2000; 20(8): 1873-1881.

- Hambidge M. J. (2000). Human zinc deficiency. J. Nutr.; 130, 1344-9.

- Lin CC, Huang JF, Tsai LY,Huang YL. J. Selenium,iron,copper and zinc levels and copper-tozinc ratios in serum of patients at different stages of viral hepatic diseases. Biol Trace Elem Res. 2006;109(1):15-24.

- Cunnane S C J. Role of zinc in lipid and fatty acid metabolism. Nutr.Sci. 1988; 12, 151-188.

- Koo I, Williams D A J. Relationship between the nutritional status of zinc and cholesterol concentration of serum lipoprotein in adult male rats. Am. J. Clin. Nutr.1981; 34:2376-2381.

- Engle T E, Spears J W, Xi L J. Concentration in fishing stress dietary copper effects on lipid metabolism and circulating catecholamine. J. Am.Sci. 2000;78:2737-2744.

- El-Hendy H A,Yousef M I, Abo El-Naga N I J. Effect of dietary zinc deficiency on hematological and biochemical parameters and concentration of zinc,copper and iron in growing rats. Toxicol. 2001;167:163-170.